Stay updated on Sepofarsen Repeat-dose in LCA10 Clinical Trial
Sign up to get notified when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.

Latest updates to the Sepofarsen Repeat-dose in LCA10 Clinical Trial page
- Check5 days agoChange DetectedThe site revision label updated from v3.4.2 to v3.4.3. This appears to be a routine maintenance update.SummaryDifference0.1%

- Check12 days agoChange DetectedUI and layout adjustments observed between the two screenshots; core study details and eligibility criteria remain unchanged.SummaryDifference0.1%

- Check19 days agoChange DetectedNo changes detected; the page content and structure appear the same.SummaryDifference0.1%

- Check34 days agoChange DetectedRevision: v3.4.2 was added; the notice about lapse in government funding was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check41 days agoChange DetectedAdded a site-wide notice about a lapse in government funding and updated the site revision to v3.4.1, replacing v3.4.0. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check48 days agoChange DetectedAdded a glossary display and updated UI/metadata to show 'Last Update Submitted that Met QC Criteria', 'No FEAR Act Data', and 'Revision: v3.4.0' (replacing lowercase labels and the older revision tag). To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to Sepofarsen Repeat-dose in LCA10 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sepofarsen Repeat-dose in LCA10 Clinical Trial page.